MAP2K1 and neoplasm: In contrast, knock-down of BRAF+CRAF, BRAF+PIK3CA, and MEK1/2+PIK3CA in IPC298 cells led to accumulation of cells in S or G1-phase consistent with the adverse effect on tumor growth observed in vivo.